AzTrials
AzTrials

Autogenous Tooth Bone GraftNCT04795102

Effect of "Autogenous Leukocyte Platelet Rich Fibrin- Tooth Graft" Combination Around Immediately Placed Implants

A study testing immediate implant placement with ATBG and L-PRF and immediate implant placement with ATBG in people with Autogenous Tooth Bone Graft and Immediate Implant Placement, run by Dalia Rasheed Issa at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Immediate implant placement into fresh extraction sockets is gaining popularity because of fewer clinical procedures and maintenance of bone architecture compared to conventional methods, thus reducing the treatment time and increasing patient satisfaction. Read more about this study

Who is it for?
Ages 18 to 50 yearsHealthy volunteers can take part
What is being tested?
immediate implant placement with ATBG and L-PRF and immediate implant placement with ATBG
Could I receive a placebo?
No, everyone receives an active treatment
How many people
26 participants
Where
1 siteEgypt
Study dates
1 Jan 2020to 2 Apr 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Teeth need to be extracted for periodontal reasons with a defect of labial bone (horizontal or vertical bone defect).
  • the teeth without acute inflammation.
  • no uncontrolled systemic disease which is not suitable for implantation.
  • Good systemic and oral health.

Who cannot join

  • patients with systemic diseases or medications known to alter healing processes
  • Psychiatric disorders.
  • Root canal treated teeth.
  • patients undergoing or who had undergone radiation therapy and chemotherapy to the head and neck region during 12 months.
  • patients with para-functional habits.
  • alcoholics.
  • drug abusers.
  • heavy smokers

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Faculty of Dentistry, Kafrelsheikh University

    Kafr ash Shaykh, 33511

Other trials in Egypt

About this study

Official title: Effect of "Autogenous Leukocyte Platelet Rich Fibrin- Tooth Graft" Combination Around Immediately Placed Implants in Periodontally Compromized Sites: A Randomized Clinical Trial

Immediate implant placement into fresh extraction sockets is gaining popularity because of fewer clinical procedures and maintenance of bone architecture compared to conventional methods, thus reducing the treatment time and increasing patient satisfaction. In addition, the survival rate of the immediate implantation is comparable to that of the healed implantation sites. Recently, ATBG made from compromised teeth was applied in bone defects and resulted in a good clinical efficacy. Moreover, it is more accepted by patients to use extracted teeth as a bone graft material, especially in the case of immediate implant placement. In 2020, Kizildağ and coworkers studied the outcome of PRF as an adjunct with ATBG on bone healing in rabbit peri-implant osseous defects. They reported that combination of ATBG with PRF contributed to significantly higher new bone formation and better bone/implant contact in rabbits with peri-implant bone defects. The main hypothesis behind this study is that using L-PRF with ATBG following immediate implant placement could promote stabilization of graft particles and enhance new bone formation with a shorter time. Therefore, the purpose of this study was to compare the clinical and radiographic outcomes of ATBG on bone formation with or without L-PRF around immediately placed dental implants in periodontally compromised teeth.

Being tested
immediate implant placement with ATBG and L-PRF, immediate implant placement with ATBG

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • immediate implant placement with ATBG and L-PRFCombination product

    immediate implant placement using ATBG as a graft material, with L-PRF

  • immediate implant placement with ATBGCombination product

    immediate implant placement using ATBG as a graft material without L-PRF

Study groups in NCT04795102
Study groupRoleWhat they receive
L-PRF with ATBG around implantExperimentalL-PRF clots to cover ATBG around immediately placed dental implants in the extraction sockets
Receives: Combination Product: immediate implant placement with ATBG and L-PRF
ATBG around implantActive comparatorATBG around immediately placed dental implants in the extraction sockets
Receives: Combination Product: immediate implant placement with ATBG

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. clinical evaluation of bone formation around immediately placed dental implants

    Changes on bone formation using ATBG with or without L-PRF around immediately placed dental implants in periodontally compromised teeth

    Measured: 9 months

  2. radiographic outcome around immediately placed dental implants

    the radiographic outcome of ATBG on bone formation with or without L-PRF around immediately placed dental implants in periodontally compromised teeth

    Measured: 9 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Mar 2021
  2. Study start1 Jan 2020
  3. Primary completion2 Apr 2021
  4. Study completion2 Apr 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
26 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04795102
Sponsor's protocol ID
KD/03/20
Status last verified
Sep 2021
First submitted
7 Mar 2021
Last updated
2 Sep 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing immediate implant placement with ATBG and L-PRF and immediate implant placement with ATBG in people with Autogenous Tooth Bone Graft and Immediate Implant Placement, run by Dalia Rasheed Issa at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Sep 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

clinical evaluation of bone formation around immediately placed dental implants (time frame: 9 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Sep 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in